Quest Laboratories Current Share Price | Quest Laboratories Stock Screener
QUESTLAB
Pharmaceuticals
Quest Laboratories Current Stock Price Today
Track the current Quest Laboratories share price and stock price live with TickJournal's free stock screener.
Browse QUESTLAB cash flow statement to support your investment research.
Use the Quest Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Quest Laboratories Market Cap
₹127.82 Cr.
QUESTLAB P/E Ratio (TTM)
15.00
Quest Laboratories P/B Ratio
-
EPS (TTM)
₹9.16
Dividend Yield
-
Debt to Equity
0.32
QUESTLAB 52 Week High
-
Quest Laboratories 52 Week Low
-
Operating Margin
16.00%
Profit Margin
13.39%
QUESTLAB Revenue (TTM)
₹112.00
EBITDA
₹18.00
Net Income
₹15.00
Total Assets
₹122.00
Total Equity
₹82.00
Quest Laboratories Current Share Price Chart
Track the current Quest Laboratories share price and stock price with an interactive chart. Analyse QUESTLAB price trends, trading volume, historical performance, and volatility across different timeframes — the complete Quest Laboratories stock quote in one place.
Quest Laboratories Company Profile - Fundamental Screener
Screen Quest Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for QUESTLAB shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE0TNW01017
Quest Laboratories Balance Sheet Screener
Screen QUESTLAB balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Total Assets | 122 | 61 | 47 | 35 | 18 |
| Current Assets | 107 | 50 | 34 | 27 | 12 |
| Fixed Assets | 12 | 10 | 10 | 7 | 6 |
| Liabilities | |||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 3 | 2 | 3 | 2 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||
| Total Equity | 82 | 29 | 15 | 10 | 6 |
| Share Capital | 16 | 12 | 1 | 1 | 1 |
| Reserves & Surplus | 65 | 17 | 14 | 9 | 5 |
Quest Laboratories Income Statement Screener - Profit & Revenue Analysis
Screen Quest Laboratories income statement and profit fundamentals.
Analyze QUESTLAB quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Quest Laboratories share price evaluation.
| Item | 2026-March | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|---|
| Revenue | 112 | 108 | 83 | 62 | 60 | 30 |
| Expenses | 94 | 88 | 67 | 54 | 53 | 29 |
| EBITDA | 18 | 20 | 16 | 8 | 7 | 2 |
| Operating Profit % | 16.00% | 15.00% | 19.00% | 13.00% | 11.00% | 5.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 0 |
| Interest | 2 | 1 | 1 | 1 | 0 | 0 |
| Profit Before Tax | 18 | 19 | 14 | 7 | 6 | 1 |
| Tax | 4 | 5 | 4 | 2 | 2 | 0 |
| Net Profit | 15 | 14 | 10 | 5 | 4 | 1 |
| EPS | 9.16 | 8.28 | 6.16 | 46.76 | 38.05 | 6.07 |
Quest Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen QUESTLAB cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March |
|---|---|---|---|---|---|
| Operating Activities | -23 | 3 | 4 | 4 | 1 |
| Investing Activities | -44 | -5 | -4 | -2 | -1 |
| Financing Activities | 67 | 2 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 1 | 0 |
Quest Laboratories Shareholding Pattern Screener
See Quest Laboratories shareholding pattern with promoter, FII, and DII holdings.
Check Quest Laboratories promoter holding and ownership changes for QUESTLAB on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Sept | 2025-Dec | 2024-Mar | 2024-May |
|---|---|---|---|---|---|---|
| Promoter Holding | 66.78% | 66.21% | 66.78% | 66.78% | 90.36% | 90.36% |
| FII Holding | 0.61% | 0.00% | 0.00% | 0.61% | 0.00% | 0.00% |
| DII Holding | 2.04% | 0.07% | 0.00% | 1.37% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 26.98% | 24.35% | 25.50% | 28.37% | 0.00% | 0.00% |
| Other Holding | 3.58% | 9.37% | 7.72% | 2.87% | 9.64% | 9.64% |
| Shareholder Count | 911 | 1,001 | 1,084 | 1,017 | 20 | 23 |
Quest Laboratories Share Dividend Screener - Share Yield Analysis
Check Quest Laboratories dividend history with payout and yield data.
View Quest Laboratories dividend details including ex-dates and amounts for QUESTLAB stock.
Quest Laboratories Stock Index Membership
See which indices include Quest Laboratories stock.
Check QUESTLAB index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Quest Laboratories Market Events Screener - Corporate Actions
Get Quest Laboratories corporate actions including splits, bonuses, and buybacks.
Check Quest Laboratories stock events that may affect QUESTLAB share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-05-29 | 2026-05-29 | Quarterly Result Announcement | NA | 0.56% |
| 2026-02-13 | 2026-02-13 | Quarterly Result Announcement | NA | 32.76% |
| 2025-11-13 | 2025-11-13 | Quarterly Result Announcement | NA | 3.02% |
| 2025-07-24 | 2025-07-24 | Quarterly Result Announcement | NA | 15.92% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | -1.43% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | 5.97% |
| 2024-09-04 | 2024-09-04 | Annual General Meeting | NA | 0.24% |
Quest Laboratories Competitors Screener - Peer Comparison
Screen QUESTLAB competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 444,717 | 36.34 | 61,674 | 12.69% | 11,565 | 38.94 |
| Divis Laboratories | 243,116 | 83.41 | 11,067 | 13.95% | 2,568 | 57.81 |
| Torrent Pharmaceuticals | 183,052 | 85.57 | 13,886 | 20.34% | 2,138 | 42.03 |
| Zydus Life Science | 111,440 | 23.87 | 27,658 | 17.64% | 5,026 | 43.86 |
| Cipla | 109,705 | 32.76 | 29,045 | 2.24% | 3,870 | 35.04 |
| Laurus Labs | 102,870 | 95.29 | 6,868 | 22.01% | 890 | 56.63 |
| Dr Reddys Laboratories | 95,152 | 30.15 | 35,059 | 3.90% | 4,158 | 39.81 |
| Aurobindo Pharma | 94,535 | 25.82 | 34,145 | 5.56% | 3,503 | 49.75 |
| Lupin | 93,504 | 16.93 | 29,039 | 26.75% | 5,356 | 22.87 |
| Mankind Pharma | 92,759 | 45.72 | 14,636 | 14.85% | 1,938 | 34.16 |
Quest Laboratories Company Announcements - News Screener
Screen QUESTLAB latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.